• Exchange: Berlin
  • Sector: Materials
  • Industry: Chemicals
  • Sub-Industry: Specialty Chemicals

Arch Therapeutics Inc

+ Add to Watchlist

A47:GR

0.144 EUR 0.0000.00%

As of 10:10:48 ET on 09/16/2014.

Snapshot for Arch Therapeutics Inc (A47)

Open: 0.145 Day's Range: 0.144 - 0.145 Volume: 0
Previous Close: 0.144 52wk Range: 0.108 - 0.320 1-Yr Rtn: -46.47%

Stock Chart for A47

No chart data available.
  • A47:GR 0.144
  • 1D
  • 1M
  • 1Y
0.144
Interactive A47 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for A47

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 10.38
Shares Outstanding (M) 72.08
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 12/26/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for A47

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for A47

Arch Therapeutics, Inc. operates as a life science company developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding.

Terrence W NorchiPresident/CEO/Co-FounderRichard E DavisCFO/Treasurer
William M Cotter "Bill"Chief Operating Officer
More Company Profile & Key Executives for A47

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil